showed a trendp = 0.063
Conversely, the Diagnostic Outcome Trial in Heart Failure (DOT-HF) trial 36 showed a trend toward higher risk of primary endpoint (ACM or hospitalization for CHF) (HR 1.52, 95% CI 0.97–2.37, log-rank p = 0.063) compared to the control group.